17 employees
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific Therapeutics.
2021
$126M
from 3 investors over 3 rounds
Solve Therapeutics, Inc. raised $126M on January 21, 2022
Investors: Surveyor Capital, Decheng Capital and General Atlantic